Big Data for Big Pharma - Malena Johannes
-40% koodiga BOOKS
Saadetis 12-18 tööpäeva jooksul
30-päevane tagastamisõigus
Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. Big Data claims to be full of insights that Big Pharma need to find a way of harvesting, which could lead to new compounds. Academics, Big Data start-ups, ... Täielik kirjeldus
Võib-olla meeldib sulle ka
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-40% koodiga BOOKS
Meie tarnija laos
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-40% koodiga BOOKS
Meie tarnija laos
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-40% koodiga BOOKS
Meie tarnija laos
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Checklist Manifesto: How to Get Things Right
-40% koodiga BOOKS
Meie tarnija laos
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-40% koodiga BOOKS
Meie tarnija laos
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-40% koodiga BOOKS
Meie tarnija laos
TOP
Lifespan: Why We Age - and Why We Don't Have To
-40% koodiga BOOKS
Meie tarnija laos
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-40% koodiga BOOKS
Meie tarnija laos
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-40% koodiga BOOKS
Meie tarnija laos
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-40% koodiga BOOKS
Meie tarnija laos
TOP
Pocket Guide to Teaching for Clinical Instructors
-40% koodiga BOOKS
Meie tarnija laos
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Wills Eye Manual: Print + eBook with Multimedia: Office and Emergency Room Diagnosis and Treatment of Eye Disease
-40% koodiga BOOKS
Meie tarnija laos
TOP
Who Deserves Your Love: How to Create Boundaries to Start, Strengthen or End Any Relationship
-40% koodiga BOOKS
Meie tarnija laos
TOP
Vaccinated - dead: Histopathological findings following COVID-19 vaccination
-40% koodiga BOOKS
Meie tarnija laos
Kirjeldus
Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. Big Data claims to be full of insights that Big Pharma need to find a way of harvesting, which could lead to new compounds. Academics, Big Data start-ups, and pharmaceutical companies have focused their research efforts on analytic tools and data technologies to store, collect, analyse, and extract these insights from massive data sets. However, the key question is whether the Big Data hype really does have the claimed accelerating effect on the complex research and development process or if it actually creates another hurdle for Big Pharma innovation. Malena Johannes' timely book sheds light on this question by examining the top 5 pharmaceutical companies and provides an overview on the status quo of Big Data applications within the pharmaceutical industry.
Lisateave
| Autor | Malena Johannes |
|---|---|
| Kirjastaja | ibidem |
| Väljalaskeaasta | 2016 |
| Kaanetüüp | Pehme kaanega |
| EAN | 9783838209425 |